BIEL vs ABT: Which Stock is Better?

Side-by-side comparison of Bioelectronics Corp and Abbott Laboratories in 2026

Comparison Updated:

BIEL

Bioelectronics Corp

$0.00

ABT

Abbott Laboratories

$121.14

Key Metrics Comparison

MetricBIELABTWinner
Market Cap$7.41M$210.84BABT
P/E RatioN/A15.22ABT
EPS (TTM)$N/A$7.96ABT
Revenue Growth-0.7%0.1%ABT
Gross Margin49.4%56.3%ABT

Analyze BIEL

Full quant analysis

Analyze ABT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BIEL or ABT a better investment?

Comparing BIEL and ABT: Bioelectronics Corp has a market cap of $7.41M while Abbott Laboratories has $210.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BIEL and ABT?

BIEL (Bioelectronics Corp) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BIEL or ABT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: BIEL or ABT?

ABT has higher revenue growth at 0.1% vs -0.7% for BIEL.

Which company is more profitable: BIEL or ABT?

Abbott Laboratories (ABT) has higher gross margins at 56.3% compared to 49.4% for BIEL.

Which is the larger company: BIEL or ABT?

Abbott Laboratories (ABT) is larger with a market cap of $210.84B compared to $7.41M for BIEL.

Should I buy BIEL or ABT in 2026?

Both BIEL and ABT have investment merit. BIEL trades at $0.00 while ABT trades at $121.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BIEL and ABT stock?

Key differences: Market Cap ($7.41M vs $210.84B), P/E Ratio (N/A vs 15.2x), Revenue Growth (-0.7% vs 0.1%), Gross Margin (49.4% vs 56.3%).

Popular Stock Comparisons